Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.305EUR
309.22 MEUR
1.78 BEUR
221.24 M
About Qiagen N.V.
Sector
Industry
CEO
Thierry Bernard
Website
Headquarters
Venlo
Employees (FY)
5.97 K
Founded
1996
ISIN
NL0015001WM6
FIGI
BBG00JCPQW46
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
An aggregate view of professional's ratings.
Frequently Asked Questions
The current price of 4QGEN is 40.320 EUR — it has decreased by −2.56% in the past 24 hours. Watch QIAGEN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange QIAGEN stocks are traded under the ticker 4QGEN.
4QGEN stock has fallen by −2.90% compared to the previous week, the month change is a −4.61% fall, over the last year QIAGEN has showed a 8.30% increase.
We've gathered analysts' opinions on QIAGEN future price: according to them, 4QGEN price has a max estimate of 54.93 EUR and a min estimate of 38.51 EUR. Watch 4QGEN chart and read a more detailed QIAGEN stock forecast: see what analysts think of QIAGEN and suggest that you do with its stocks.
4QGEN reached its all-time high on Nov 26, 2021 with the price of 50.260 EUR, and its all-time low was 23.300 EUR and was reached on Oct 8, 2019. View more price dynamics on 4QGEN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4QGEN stock is 2.63% volatile and has beta coefficient of 0.76. Track QIAGEN stock price on the chart and check out the list of the most volatile stocks — is QIAGEN there?
Today QIAGEN has the market capitalization of 9.06 B, it has decreased by −0.16% over the last week.
Yes, you can track QIAGEN financials in yearly and quarterly reports right on TradingView.
QIAGEN is going to release the next earnings report on Oct 30, 2024. Keep track of upcoming events with our Earnings Calendar.
4QGEN earnings for the last quarter are 0.51 EUR per share, whereas the estimation was 0.49 EUR resulting in a 5.66% surprise. The estimated earnings for the next quarter are 0.49 EUR per share. See more details about QIAGEN earnings.
QIAGEN revenue for the last quarter amounts to 463.39 M EUR, despite the estimated figure of 462.56 M EUR. In the next quarter, revenue is expected to reach 440.33 M EUR.
4QGEN net income for the last quarter is −171.28 M EUR, while the quarter before that showed 74.77 M EUR of net income which accounts for −329.08% change. Track more QIAGEN financial stats to get the full picture.
QIAGEN dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 21, 2024, the company has 5.97 K employees. See our rating of the largest employees — is QIAGEN on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. QIAGEN EBITDA is 615.81 M EUR, and current EBITDA margin is 33.10%. See more stats in QIAGEN financial statements.
Like other stocks, 4QGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QIAGEN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So QIAGEN technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating QIAGEN stock shows the neutral signal. See more of QIAGEN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.